MV Capital Management Inc. Makes New Investment in CME Group Inc. $CME

by · The Markets Daily

MV Capital Management Inc. purchased a new position in shares of CME Group Inc. (NASDAQ:CME – Free Report) during the 4th quarter, HoldingsChannel reports. The firm purchased 9,825 shares of the financial services provider’s stock, valued at approximately $2,683,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Asset Dedication LLC boosted its holdings in CME Group by 64.9% in the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 37 shares in the last quarter. FNY Investment Advisers LLC acquired a new position in CME Group during the fourth quarter worth $27,000. Elkhorn Partners Limited Partnership bought a new position in CME Group during the fourth quarter valued at about $27,000. Hilton Head Capital Partners LLC bought a new position in CME Group during the fourth quarter valued at about $28,000. Finally, Legacy Wealth Managment LLC ID lifted its position in shares of CME Group by 191.9% in the fourth quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after buying an additional 71 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

Insider Activity at CME Group

In other CME Group news, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $298.51, for a total value of $10,447,850.00. Following the transaction, the chief executive officer directly owned 55,630 shares of the company’s stock, valued at $16,606,111.30. The trade was a 38.62% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Hilda Harris Piell sold 5,753 shares of the company’s stock in a transaction that occurred on Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the transaction, the insider owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. This trade represents a 17.20% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.30% of the stock is owned by corporate insiders.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

  • Neutral Sentiment: CME announced a planned CEO succession: longtime chief Terry Duffy will step down in March 2027 and transition to executive chairman, while President and CFO Lynne Fitzpatrick will become CEO. The move also makes Fitzpatrick CME’s first woman chief executive, which supports continuity but adds some near-term uncertainty around the handoff. Article Title
  • Neutral Sentiment: The company also highlighted its long-term leadership change in multiple interviews and reports, which may reassure investors that the transition is orderly rather than sudden. Article Title
  • Negative Sentiment: CME said it plans to sue the CFTC over approval of crypto perpetual futures, arguing the regulator is improperly treating these products as swaps rather than futures. The legal fight raises regulatory risk and could create uncertainty around CME’s crypto derivatives strategy. Article Title
  • Negative Sentiment: Several headlines repeated the lawsuit plan, suggesting the issue is the main driver of today’s weakness as investors focus on possible friction with regulators and the implications for future product approvals. Article Title

Analysts Set New Price Targets

CME has been the subject of several recent analyst reports. Keefe, Bruyette & Woods upgraded CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price target for the company in a research note on Thursday. The Goldman Sachs Group cut their price objective on CME Group from $275.00 to $267.00 and set a “sell” rating on the stock in a research note on Thursday, April 23rd. Deutsche Bank Aktiengesellschaft reduced their target price on CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a report on Thursday, April 23rd. TD Cowen decreased their target price on CME Group from $340.00 to $323.00 and set a “buy” rating for the company in a research report on Thursday, April 23rd. Finally, Weiss Ratings downgraded CME Group from a “buy (a-)” rating to a “buy (b+)” rating in a report on Thursday, June 11th. Twelve research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $305.18.

Get Our Latest Report on CME Group

CME Group Stock Down 2.4%

CME Group stock opened at $246.38 on Friday. The firm has a market cap of $89.28 billion, a price-to-earnings ratio of 21.02, a P/E/G ratio of 2.82 and a beta of 0.21. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a fifty-two week low of $244.56 and a fifty-two week high of $329.16. The firm has a fifty day moving average price of $280.74 and a two-hundred day moving average price of $287.50.

CME Group (NASDAQ:CME – Get Free Report) last released its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. The company had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.77 billion. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The business’s quarterly revenue was up 14.5% compared to the same quarter last year. During the same period in the prior year, the company earned $2.80 earnings per share. As a group, analysts forecast that CME Group Inc. will post 12.28 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be given a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a dividend yield of 2.1%. The ex-dividend date of this dividend is Tuesday, June 9th. CME Group’s payout ratio is currently 44.37%.

CME Group Company Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).